• Amarildo Prendi

Covid-19 Vaccines Can Protect Us From Other Coronaviruses, According to a New Study

A ​​new Northwestern University Medicine study published Friday shows that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses.



The findings were recently posted in the Journal of Clinical Investigation.

The study found that plasma from humans who had been vaccinated against COVID-19 produced antibodies that were cross-reactive against SARS-CoV-1 and the “common cold” coronavirus (officially named HCoV-OC43), meaning they would potentially provide protection against numerous different kinds of coronaviruses.


NIH Study Indicates J&J Vaccine Recipients Could Benefit From Pfizer, Moderna Boosters

The SARS-CoV-1 pandemic began in China in 2002, claiming the lives of 774 victims in total.

The study additionally discovered that prior coronavirus infections can protect against subsequent infections with other coronaviruses. For example, someone with immunity against SARS-CoV-1 would likely be protected against COVID-19.

This undated transmission electron microscope image shows SARS-CoV-2, additionally known as novel coronavirus, the virus that causes COVID-19, isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab.


This undated transmission electron microscope image shows SARS-CoV-2, additionally known as novel coronavirus, the virus that causes COVID-19, isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab.


Lastly, the scientists discovered several findings from their tests on mice. The mice immunized with a SARS-CoV-1 vaccine developed in 2004 generated immune responses that protected them from nasal exposure of the SARS-CoV-2 virus, which caused the COVID-19 disease.

“As long as the coronavirus is greater than 70% related, the mice were protected,” researcher Pablo Penaloza-MacMaster said. “If they were exposed to a very different family of coronaviruses, the vaccines might confer less protection,” he added. This was seemingly confirmed by the immunized mice having much less protection against the “common cold” coronavirus.


The reason, the researchers explain, is because SARS-CoV-1 and SARS-CoV-2 are genetically similar, while the common cold coronavirus in addition contrasts from SARS-CoV-2.

“Our study helps us re-evaluate the concept of a universal coronavirus vaccine,” Penaloza-MacMaster states. “It’s likely there isn’t one, but we might end up with a generic vaccine for each of the most important families of coronaviruses.”

Penaloza-MacMaster has studied HIV vaccines over the course of the last decade. His knowledge about HIV virus mutations led him to question cross-reactivity within coronavirus vaccines.


“A reason we don’t have an effective HIV vaccine is because it’s hard to develop cross-reactive antibodies, so we thought, ‘What if we tackle the problem of coronavirus variability (which is critical for developing universal coronavirus vaccines) the same way we’re tackling HIV vaccine development?’”


Researchers Tanushree Dangi and Nicole Palacio, both from Penaloza-MacMaster’s lab at Northwestern university, co-authored the study. Funding for the study was provided by means of the United States National Institutes of Health.


Source: Jerusalem Post

5 views0 comments